U.S. Justice Dept. (DOJ)
CareFusion pays out $41M in ChloraPrep settlement
CareFusion (NYSE:CFN) said it closed out the $41 million settlement of a 2-year federal investigation into the marketing of its ChloraPrep antiseptic skin preparation wipes.
DOJ recovers $3.8B from False Claims cases, mostly over health fraud | MassDevice.com On Call
MASSDEVICE ON CALL — Federal regulators last fiscal year secured $3.8 billion in settlements of whistleblower lawsuits, the 2nd-highest take in Justice Dept. history, surpassed only by the $5 billion recovered in 2012.
The vast majority of settlement dollars came from healthcare fraud cases, comprising about $2.6 billion, according to a DoJ report.
ArthroCare settles $400M fraud scheme with $30M fine
ArthroCare (NSDQ:ARTC) and the U.S. Justice Dept. yesterday agreed to settle the $400 million fraud case against the medical device company with a $30 million fine and a 2-year deferred prosecution deal.
ArthroCare misses the mark with Q3 earnings
ArthroCare (NSDQ:ARTC) missed Wall Street’s forecast for its 3rd-quarter earnings, sending share prices down nearly 3% this week.
Boston Scientific legal update: Guidant, Guidezilla and ongoing arguments
Medical device giant Boston Scientific (NYSE:BSX) listed no fewer than a dozen legal battles in its latest financial report, notching some wins, some losses and some seemingly circuitous fights without end.
Cardiologist must cough up $17M in false Medicare billing case
A Washington, D.C., cardiologist was hit with a $17 million judgment after being found guilty of submitting false claims for nuclear imaging tests to Medicare and state health programs.
Something smells fishy with doc-owned medtech distributors | MassDevice.com On Call
MASSDEVICE ON CALL — The Justice Dept. is taking a closer look at physician-owned distributorships, warning that the influence that doctors have over hospitals purchasing practices leaves room for some serious conflicts of interest.
Michigan spine surgeon Dr. Aria Sabit took center stage in the DOJ’s broader investigation of POD centers that allow docs to take a cut of profits.
Ex-ArthroCare exec changes plea to guilty in stock fraud scheme
Former ArthroCare (NSDQ:ARTC) executive John Raffle changed his plea to guilty last month, admitting to charges that he took part in a scheme to artificially inflate ARTC stock prices by misleading investors.
Feds indict ex-ArthroCare CEO, CFO in $400M fraud scheme
Federal prosecutors in Texas indicted the former CEO and CFO of ArthroCare (NSDQ:ARTC) on 17 counts of conspiracy to commit fraud for their alleged roles in running a $400 million scheme designed to defraud investors.